Skip to main content
OpenTrials
Completed

NCT Number: NCT02154698

22-gauge ProCore Needle v. Standard 22-gauge (P00030500)

The purpose of this study is to compare the usefulness of two needles (used for obtaining a lung tissue sample : (1) standard 22-gauge, and (2) ProCore 22-gauge) for endobronchial ultrasound

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Florida, Gainesville, Florida, United States

Loading trial locations.

About this study

The purpose of this study is to compare the usefulness of two needles used for obtaining a lung tissue sample: (1) standard 22-gauge, and (2) ProCore 22-gauge. Both of these needles are used to get biopsies (samples) of lung tissue. The standard needle has one bevel (angled side of the needle formed when it is sharpened to make a point), while the ProCore needle has 2 bevels. The standard needle is more commonly used and we are doing this study to see if the ProCore needle would be more useful.

The investigator in charge of this study is Dr. Nichole T. Tanner. This study is being done at four sites and will involve approximately 200 volunteers.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects with known or suspected lung cancer with mediastinal adenopathy as defined by a mediastinal lymph node >1 cm in short axis or a normal sized lymph node with uptake on FDG-PET scan that is higher than background PET activity.
  • Participants must be at least 18 years old or older, lack bleeding disorders, and be able to provide informed consent. The latter two criteria will be assessed from the patient's history and the consenting interview.

Exclusion criteria

  • Subjects who refuse to participate, or demonstrate inability to give informed consent
  • Subjects who are less than 18 years of age
  • Subjects who lack fitness for flexible bronchoscopy as determined by the physician performing the bronchoscopy before the procedure
  • Subjects with suspected sarcoidosis, lymphoma, or metastatic cancer from other sites (i.e. those without a known or suspected lung primary)
  • Subjects on anticoagulation (other than Aspirin) whom cannot have their anticoagulation held for the procedure due to other clinical reasons (i.e. recent cardiac stent placement).

Treatment and study plan

22-gauge Standard Needle

Other

Acquisition of lymph nodes samples using the 22-gauge Standard Needle, following subject-sedation and the introduction of an EBUS scope into the airway.

22-gauge ProCore Needle

Other

Acquisition of lymph nodes samples using the 22-gauge ProCore Needle, following subject-sedation and the introduction of an EBUS scope into the airway.

Primary outcomes

  1. Ease of use of 22-gauge ProCore EBUS needles and the standard 22-gauge needles.

    Time frame: Within two weeks from the day of the procedure

  2. Quality of tumor obtained (measured by cell block and ability to perform mutational analysis)

    Time frame: Within two weeks from the day of the procedure

  3. Quantity of tissue obtained (measured by number of unstructured fragments)

    Time frame: Within two weeks from the day of the procedure

Sponsors and collaborators

Lead sponsor

Medical University of South Carolina

Other

Collaborators

  • Cook Endoscopy
  • Johns Hopkins University
  • Thoraxklinik-Heidelberg gGmbH
  • University of North Carolina

Registry information

Official study title

A Multi-center Study Comparing Standard 22-gauge and 22-gauge ProCore Needles for Endobronchial Ultrasound

Important dates

Study start
2014
Primary completion
2017
Study completion
2017
First posted
Jun 3, 2014
Registry last updated
Apr 30, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.